What happened to Cubist Pharmaceuticals?
Cubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. ….Cubist Pharmaceuticals.
| Type | Subsidiary (formerly: Public) |
|---|---|
| Defunct | 2015 |
| Headquarters | Lexington, Massachusetts |
| Key people | Robert J. Perez, President, CEO; |
| Products | Product Pipeline |
Who bought Cubist Pharmaceuticals?
Merck
Drug giant Merck said it will buy Cubist Pharmaceuticals for about $9.5 billion, or $102 a share in cash, bringing Merck a slate of medicines administered in the hospital setting, many for bacterial infections.
What happened to Michael Bonney?
Michael was very much a part of the Orange Bikes family and as many of you will know suffered a life changing injury in March 2013 which left him paralysed from the neck down.
Cubist Pharmaceuticals. The company employs 638 people, with 370 in their headquarters in Lexington, MA. As of 2011, the company’s headquarters are under expansion and is expected to occupy 373,000 sq ft (34,700 m 2) in Lexington, MA. On 8 December 2014, Merck & Co. acquired Cubist for $102 per share in cash…
What does cubcubist pharmaceuticals mean?
Cubist Pharmaceuticals was an American biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products.
When did Cubist Pharmaceuticals buy Adolor?
In 2011, the company acquired Adolor, maker of a drug for treatment of constipation. The company expected sales of its drug Cubicin to grow to more than 1 billion dollars per year. In July 2013, Cubist Pharmaceuticals agreed to purchase Trius Therapeutics and Optimer Pharmaceuticals for around $1.6 billion.
Who is the founder of Cubist?
Cubist was founded in May 1992 by John K. Clarke, Paul R. Schimmel, Ph.D. and Barry Bloom, Ph.D, all of whom were also directors. Cubist appeared on Fortune 2010’s List of fastest growing companies, and was named to the 2010 Deloitte Technology Fast 500.
